Mankind Pharma Past Earnings Performance
Past criteria checks 6/6
Mankind Pharma has been growing earnings at an average annual rate of 13.9%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 13.2% per year. Mankind Pharma's return on equity is 20.4%, and it has net margins of 17.4%.
Key information
13.9%
Earnings growth rate
13.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 13.2% |
| Return on equity | 20.4% |
| Net Margin | 17.4% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Mankind Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 99,463 | 17,271 | 25,832 | 0 |
| 30 Sep 23 | 94,303 | 15,575 | 24,863 | 0 |
| 30 Jun 23 | 91,481 | 14,762 | 20,174 | 0 |
| 31 Mar 23 | 87,494 | 12,819 | 23,126 | 0 |
| 31 Dec 22 | 84,225 | 11,865 | 22,717 | 0 |
| 31 Mar 22 | 77,816 | 14,335 | 20,934 | 0 |
| 31 Mar 21 | 62,144 | 12,654 | 18,195 | 0 |
| 31 Mar 20 | 58,719 | 10,304 | 16,082 | 0 |
| 31 Mar 19 | 49,800 | 5,785 | 14,709 | 0 |
Quality Earnings: MANKIND has high quality earnings.
Growing Profit Margin: MANKIND's current net profit margins (17.4%) are higher than last year (14.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MANKIND's earnings have grown by 13.9% per year over the past 5 years.
Accelerating Growth: MANKIND's earnings growth over the past year (45.6%) exceeds its 5-year average (13.9% per year).
Earnings vs Industry: MANKIND earnings growth over the past year (45.6%) exceeded the Pharmaceuticals industry 23.3%.
Return on Equity
High ROE: MANKIND's Return on Equity (20.4%) is considered high.